Physician profile

Malcolm P Taylor

Cardiovascular Disease · Flowood, MS

NPI 1720092414

$1,838.65

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$123.49

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $1,160.59 2020-2022
Abbott Laboratories $348.33 2019-2022
Medtronic, INC. $123.49 2023 Signia
Amarin Pharma, INC. $120.63 2019
Akcea Therapeutics, INC. $36.04 2020
Braemar Manufacturing, LLC $18.67 2019
Philips North America LLC $13.90 2020
Janssen Pharmaceuticals, INC $12.92 2020
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $4.08 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Malcolm P Taylor

$1,838.65

in general payments reported 2019-2025

Years
2019-2023
Top company
Intuitive Surgical, INC.

https://glasscript.com/doctor/350366/malcolm-p-taylor

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.